Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.

about

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.

Item

http://www.wikidata.org/entity/Q38627286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.

@en

type

Item

label

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.

@en

prefLabel

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies.

@en

P1476

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies

@en

P2093

Hope Northrup

http://www.w3.org/2001/XMLSchema#string

Jessica M Davis

http://www.w3.org/2001/XMLSchema#string

Joanne M Nguyen

http://www.w3.org/2001/XMLSchema#string

Mary Kay Koenig

http://www.w3.org/2001/XMLSchema#string

S Shahrukh Hashmi

http://www.w3.org/2001/XMLSchema#string

P2860

Three approaches to qualitative content analysis

METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment.

Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.

Prevalence of lysosomal storage disorders.

Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement.

Gaucher disease: Perspectives on a prototype lysosomal disease.

Relationship among chelator adherence, change in chelators, and quality of life in thalassemia.

Understanding patient preferences and willingness to pay for hemophilia therapies.

P304

169-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10897-017-0137-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Victoria F Wagner

P577

2017-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28803392

http://www.w3.org/2001/XMLSchema#string

P932

5794801

http://www.w3.org/2001/XMLSchema#string